img

Global Acute Kidney Injury Treatment & Management Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Acute Kidney Injury Treatment & Management Market Research Report 2024

KI happens in people who are already sick and in the hospital. People who are in the intensive care unit (ICU) are even more likely than people who are in other units of the hospital to have AKI. This is because people who need to be in the ICU are already very sick.
According to MRAResearch’s new survey, global Acute Kidney Injury Treatment & Management market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acute Kidney Injury Treatment & Management market research.
Key companies engaged in the Acute Kidney Injury Treatment & Management industry include B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Medical Co., Ltd, Angion Biomedica Corp, AM-Pharma, Quark Pharmaceuticals, Inc and Fresenius Medical Care AG & Co. KGaA, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Acute Kidney Injury Treatment & Management were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Acute Kidney Injury Treatment & Management market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Acute Kidney Injury Treatment & Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


B. Braun Melsungen AG
Baxter International, Inc.
Asahi Kasei Medical Co., Ltd
Angion Biomedica Corp
AM-Pharma
Quark Pharmaceuticals, Inc
Fresenius Medical Care AG & Co. KGaA
Segment by Type
Prerenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury
Postrenal Acute Kidney Injury

Segment by Application


Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acute Kidney Injury Treatment & Management report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Kidney Injury Treatment & Management Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Prerenal Acute Kidney Injury
1.2.3 Intrinsic Renal Acute Kidney Injury
1.2.4 Postrenal Acute Kidney Injury
1.3 Market by Application
1.3.1 Global Acute Kidney Injury Treatment & Management Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Kidney Injury Treatment & Management Market Perspective (2018-2033)
2.2 Acute Kidney Injury Treatment & Management Growth Trends by Region
2.2.1 Global Acute Kidney Injury Treatment & Management Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Acute Kidney Injury Treatment & Management Historic Market Size by Region (2018-2023)
2.2.3 Acute Kidney Injury Treatment & Management Forecasted Market Size by Region (2024-2033)
2.3 Acute Kidney Injury Treatment & Management Market Dynamics
2.3.1 Acute Kidney Injury Treatment & Management Industry Trends
2.3.2 Acute Kidney Injury Treatment & Management Market Drivers
2.3.3 Acute Kidney Injury Treatment & Management Market Challenges
2.3.4 Acute Kidney Injury Treatment & Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Kidney Injury Treatment & Management Players by Revenue
3.1.1 Global Top Acute Kidney Injury Treatment & Management Players by Revenue (2018-2023)
3.1.2 Global Acute Kidney Injury Treatment & Management Revenue Market Share by Players (2018-2023)
3.2 Global Acute Kidney Injury Treatment & Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Kidney Injury Treatment & Management Revenue
3.4 Global Acute Kidney Injury Treatment & Management Market Concentration Ratio
3.4.1 Global Acute Kidney Injury Treatment & Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Kidney Injury Treatment & Management Revenue in 2022
3.5 Acute Kidney Injury Treatment & Management Key Players Head office and Area Served
3.6 Key Players Acute Kidney Injury Treatment & Management Product Solution and Service
3.7 Date of Enter into Acute Kidney Injury Treatment & Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Kidney Injury Treatment & Management Breakdown Data by Type
4.1 Global Acute Kidney Injury Treatment & Management Historic Market Size by Type (2018-2023)
4.2 Global Acute Kidney Injury Treatment & Management Forecasted Market Size by Type (2024-2033)
5 Acute Kidney Injury Treatment & Management Breakdown Data by Application
5.1 Global Acute Kidney Injury Treatment & Management Historic Market Size by Application (2018-2023)
5.2 Global Acute Kidney Injury Treatment & Management Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Acute Kidney Injury Treatment & Management Market Size (2018-2033)
6.2 North America Acute Kidney Injury Treatment & Management Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Acute Kidney Injury Treatment & Management Market Size by Country (2018-2023)
6.4 North America Acute Kidney Injury Treatment & Management Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Kidney Injury Treatment & Management Market Size (2018-2033)
7.2 Europe Acute Kidney Injury Treatment & Management Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Acute Kidney Injury Treatment & Management Market Size by Country (2018-2023)
7.4 Europe Acute Kidney Injury Treatment & Management Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Kidney Injury Treatment & Management Market Size (2018-2033)
8.2 Asia-Pacific Acute Kidney Injury Treatment & Management Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Acute Kidney Injury Treatment & Management Market Size by Region (2018-2023)
8.4 Asia-Pacific Acute Kidney Injury Treatment & Management Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Kidney Injury Treatment & Management Market Size (2018-2033)
9.2 Latin America Acute Kidney Injury Treatment & Management Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Acute Kidney Injury Treatment & Management Market Size by Country (2018-2023)
9.4 Latin America Acute Kidney Injury Treatment & Management Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Kidney Injury Treatment & Management Market Size (2018-2033)
10.2 Middle East & Africa Acute Kidney Injury Treatment & Management Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Acute Kidney Injury Treatment & Management Market Size by Country (2018-2023)
10.4 Middle East & Africa Acute Kidney Injury Treatment & Management Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Company Detail
11.1.2 B. Braun Melsungen AG Business Overview
11.1.3 B. Braun Melsungen AG Acute Kidney Injury Treatment & Management Introduction
11.1.4 B. Braun Melsungen AG Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023)
11.1.5 B. Braun Melsungen AG Recent Development
11.2 Baxter International, Inc.
11.2.1 Baxter International, Inc. Company Detail
11.2.2 Baxter International, Inc. Business Overview
11.2.3 Baxter International, Inc. Acute Kidney Injury Treatment & Management Introduction
11.2.4 Baxter International, Inc. Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023)
11.2.5 Baxter International, Inc. Recent Development
11.3 Asahi Kasei Medical Co., Ltd
11.3.1 Asahi Kasei Medical Co., Ltd Company Detail
11.3.2 Asahi Kasei Medical Co., Ltd Business Overview
11.3.3 Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment & Management Introduction
11.3.4 Asahi Kasei Medical Co., Ltd Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023)
11.3.5 Asahi Kasei Medical Co., Ltd Recent Development
11.4 Angion Biomedica Corp
11.4.1 Angion Biomedica Corp Company Detail
11.4.2 Angion Biomedica Corp Business Overview
11.4.3 Angion Biomedica Corp Acute Kidney Injury Treatment & Management Introduction
11.4.4 Angion Biomedica Corp Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023)
11.4.5 Angion Biomedica Corp Recent Development
11.5 AM-Pharma
11.5.1 AM-Pharma Company Detail
11.5.2 AM-Pharma Business Overview
11.5.3 AM-Pharma Acute Kidney Injury Treatment & Management Introduction
11.5.4 AM-Pharma Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023)
11.5.5 AM-Pharma Recent Development
11.6 Quark Pharmaceuticals, Inc
11.6.1 Quark Pharmaceuticals, Inc Company Detail
11.6.2 Quark Pharmaceuticals, Inc Business Overview
11.6.3 Quark Pharmaceuticals, Inc Acute Kidney Injury Treatment & Management Introduction
11.6.4 Quark Pharmaceuticals, Inc Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023)
11.6.5 Quark Pharmaceuticals, Inc Recent Development
11.7 Fresenius Medical Care AG & Co. KGaA
11.7.1 Fresenius Medical Care AG & Co. KGaA Company Detail
11.7.2 Fresenius Medical Care AG & Co. KGaA Business Overview
11.7.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment & Management Introduction
11.7.4 Fresenius Medical Care AG & Co. KGaA Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023)
11.7.5 Fresenius Medical Care AG & Co. KGaA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acute Kidney Injury Treatment & Management Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Prerenal Acute Kidney Injury
Table 3. Key Players of Intrinsic Renal Acute Kidney Injury
Table 4. Key Players of Postrenal Acute Kidney Injury
Table 5. Global Acute Kidney Injury Treatment & Management Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Acute Kidney Injury Treatment & Management Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Acute Kidney Injury Treatment & Management Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Acute Kidney Injury Treatment & Management Market Share by Region (2018-2023)
Table 9. Global Acute Kidney Injury Treatment & Management Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Acute Kidney Injury Treatment & Management Market Share by Region (2024-2033)
Table 11. Acute Kidney Injury Treatment & Management Market Trends
Table 12. Acute Kidney Injury Treatment & Management Market Drivers
Table 13. Acute Kidney Injury Treatment & Management Market Challenges
Table 14. Acute Kidney Injury Treatment & Management Market Restraints
Table 15. Global Acute Kidney Injury Treatment & Management Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Acute Kidney Injury Treatment & Management Market Share by Players (2018-2023)
Table 17. Global Top Acute Kidney Injury Treatment & Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Treatment & Management as of 2022)
Table 18. Ranking of Global Top Acute Kidney Injury Treatment & Management Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Acute Kidney Injury Treatment & Management Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Kidney Injury Treatment & Management Product Solution and Service
Table 22. Date of Enter into Acute Kidney Injury Treatment & Management Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Kidney Injury Treatment & Management Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Acute Kidney Injury Treatment & Management Revenue Market Share by Type (2018-2023)
Table 26. Global Acute Kidney Injury Treatment & Management Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Acute Kidney Injury Treatment & Management Revenue Market Share by Type (2024-2033)
Table 28. Global Acute Kidney Injury Treatment & Management Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Acute Kidney Injury Treatment & Management Revenue Market Share by Application (2018-2023)
Table 30. Global Acute Kidney Injury Treatment & Management Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Acute Kidney Injury Treatment & Management Revenue Market Share by Application (2024-2033)
Table 32. North America Acute Kidney Injury Treatment & Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Acute Kidney Injury Treatment & Management Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Acute Kidney Injury Treatment & Management Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Acute Kidney Injury Treatment & Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Acute Kidney Injury Treatment & Management Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Acute Kidney Injury Treatment & Management Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Acute Kidney Injury Treatment & Management Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Acute Kidney Injury Treatment & Management Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Acute Kidney Injury Treatment & Management Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Acute Kidney Injury Treatment & Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Acute Kidney Injury Treatment & Management Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Acute Kidney Injury Treatment & Management Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Acute Kidney Injury Treatment & Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Acute Kidney Injury Treatment & Management Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Acute Kidney Injury Treatment & Management Market Size by Country (2024-2033) & (US$ Million)
Table 47. B. Braun Melsungen AG Company Detail
Table 48. B. Braun Melsungen AG Business Overview
Table 49. B. Braun Melsungen AG Acute Kidney Injury Treatment & Management Product
Table 50. B. Braun Melsungen AG Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023) & (US$ Million)
Table 51. B. Braun Melsungen AG Recent Development
Table 52. Baxter International, Inc. Company Detail
Table 53. Baxter International, Inc. Business Overview
Table 54. Baxter International, Inc. Acute Kidney Injury Treatment & Management Product
Table 55. Baxter International, Inc. Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023) & (US$ Million)
Table 56. Baxter International, Inc. Recent Development
Table 57. Asahi Kasei Medical Co., Ltd Company Detail
Table 58. Asahi Kasei Medical Co., Ltd Business Overview
Table 59. Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment & Management Product
Table 60. Asahi Kasei Medical Co., Ltd Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023) & (US$ Million)
Table 61. Asahi Kasei Medical Co., Ltd Recent Development
Table 62. Angion Biomedica Corp Company Detail
Table 63. Angion Biomedica Corp Business Overview
Table 64. Angion Biomedica Corp Acute Kidney Injury Treatment & Management Product
Table 65. Angion Biomedica Corp Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023) & (US$ Million)
Table 66. Angion Biomedica Corp Recent Development
Table 67. AM-Pharma Company Detail
Table 68. AM-Pharma Business Overview
Table 69. AM-Pharma Acute Kidney Injury Treatment & Management Product
Table 70. AM-Pharma Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023) & (US$ Million)
Table 71. AM-Pharma Recent Development
Table 72. Quark Pharmaceuticals, Inc Company Detail
Table 73. Quark Pharmaceuticals, Inc Business Overview
Table 74. Quark Pharmaceuticals, Inc Acute Kidney Injury Treatment & Management Product
Table 75. Quark Pharmaceuticals, Inc Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023) & (US$ Million)
Table 76. Quark Pharmaceuticals, Inc Recent Development
Table 77. Fresenius Medical Care AG & Co. KGaA Company Detail
Table 78. Fresenius Medical Care AG & Co. KGaA Business Overview
Table 79. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment & Management Product
Table 80. Fresenius Medical Care AG & Co. KGaA Revenue in Acute Kidney Injury Treatment & Management Business (2018-2023) & (US$ Million)
Table 81. Fresenius Medical Care AG & Co. KGaA Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Kidney Injury Treatment & Management Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Acute Kidney Injury Treatment & Management Market Share by Type: 2022 VS 2033
Figure 3. Prerenal Acute Kidney Injury Features
Figure 4. Intrinsic Renal Acute Kidney Injury Features
Figure 5. Postrenal Acute Kidney Injury Features
Figure 6. Global Acute Kidney Injury Treatment & Management Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Acute Kidney Injury Treatment & Management Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Acute Kidney Injury Treatment & Management Report Years Considered
Figure 12. Global Acute Kidney Injury Treatment & Management Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Acute Kidney Injury Treatment & Management Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Acute Kidney Injury Treatment & Management Market Share by Region: 2022 VS 2033
Figure 15. Global Acute Kidney Injury Treatment & Management Market Share by Players in 2022
Figure 16. Global Top Acute Kidney Injury Treatment & Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Treatment & Management as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Acute Kidney Injury Treatment & Management Revenue in 2022
Figure 18. North America Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Acute Kidney Injury Treatment & Management Market Share by Country (2018-2033)
Figure 20. United States Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Acute Kidney Injury Treatment & Management Market Share by Country (2018-2033)
Figure 24. Germany Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Acute Kidney Injury Treatment & Management Market Share by Region (2018-2033)
Figure 32. China Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Acute Kidney Injury Treatment & Management Market Share by Country (2018-2033)
Figure 40. Mexico Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Acute Kidney Injury Treatment & Management Market Share by Country (2018-2033)
Figure 44. Turkey Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Acute Kidney Injury Treatment & Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. B. Braun Melsungen AG Revenue Growth Rate in Acute Kidney Injury Treatment & Management Business (2018-2023)
Figure 47. Baxter International, Inc. Revenue Growth Rate in Acute Kidney Injury Treatment & Management Business (2018-2023)
Figure 48. Asahi Kasei Medical Co., Ltd Revenue Growth Rate in Acute Kidney Injury Treatment & Management Business (2018-2023)
Figure 49. Angion Biomedica Corp Revenue Growth Rate in Acute Kidney Injury Treatment & Management Business (2018-2023)
Figure 50. AM-Pharma Revenue Growth Rate in Acute Kidney Injury Treatment & Management Business (2018-2023)
Figure 51. Quark Pharmaceuticals, Inc Revenue Growth Rate in Acute Kidney Injury Treatment & Management Business (2018-2023)
Figure 52. Fresenius Medical Care AG & Co. KGaA Revenue Growth Rate in Acute Kidney Injury Treatment & Management Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed